PQ 312
345 Mr. J. O’Keeffe asked the Minister for Health and Children if his attention has been drawn to the fact that the warnings issued in the USA and Canada in relation to the use of antidepressants known as selective serotonin reuptake inhibitors are much stronger than those applicable here, or throughout the European Union; and if he will take steps to ensure that the documentation for the future will be more specific in relation to warnings and precautions for use of such drugs. [20125/04]
Introduced
6 July 2004
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
6 July 2004
Summary
345 Mr. J. O’Keeffe asked the Minister for Health and Children if his attention has been drawn to the fact that the warnings issued in the USA and Canada in relation to the use of antidepressants known as selective serotonin reuptake inhibitors are much stronger than those applicable here, or throughout the European Union; and if he will take steps to ensure that the documentation for the future will be more specific in relation to warnings and precautions for use of such drugs. [20125/04]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products.
Medicinal Products.
xml · EN · 6 July 2004
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2004-07-06/312/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2004-07-06/pq_312